Key Takeaways
- • Corgi, an insurtech company serving startups, raised $106 million in Series B1 funding at a $2.6 billion valuation, exactly doubling its $1.3 billion valuation from three weeks prior (Series B round of $160 million).
- • The rapid sequential funding—$108 million Series A (four months prior), $160 million Series B, then $106 million Series B1 within three weeks—with identical investor participation across rounds is drawing scrutiny from limited partners over valuation markup practices.
- • Series B1 was led by TCV with participation from existing investors including Kindred Ventures, Prime Capital, Leblon Capital, Alumni Ventures, and Y Combinator; the company serves customers including Deel and Artisan.
- • Kindred Ventures investor Kanyi Maqubela attributed the valuation jump to company momentum, but acknowledged growing LP concern that rapid internal markups without liquidity events can inflate portfolio performance metrics and lack real business justification.
- • The case highlights broader tension in venture markets regarding mark-to-market practices, with institutional investors increasingly distinguishing between actual exit-driven revaluations and paper markups that may not reflect underlying fundamentals.
Summary
The rapid cadence of capital raises is extraordinary by any measure. Corgi raised $108 million in Series A four months prior, followed by $160 million in Series B three weeks before this latest round. The sequential nature of these transactions, combined with a valuation that doubled in 21 days and identical investor participation across both recent rounds, has triggered questions from institutional capital providers about the economic substance underlying such steep step-ups.
When pressed on what material business development justified a 100% valuation increase in three weeks, Kindred Ventures' Kanyi Maqubela pointed to operational momentum. However, this explanation has not fully satisfied limited partners. One LP managing capital across multiple venture funds, speaking anonymously, noted growing institutional skepticism around "internal markups" divorced from actual liquidity events. "If a company is just getting re-priced upward with no real liquidity event, LPs notice," the LP stated, adding that this practice can artificially inflate fund portfolio performance metrics on paper while obscuring whether underlying business fundamentals justify the new valuations.
Maqubela countered that LP concerns about markups are addressed by the fact that institutional capital providers ultimately "discount the value of markups since those aren't always reflective of reality," and that they instead prioritize actual exit events. He also suggested that Kindred's LPs and Corgi's other backers have not expressed concern about the valuation progression. Nevertheless, the case has surfaced a broader institutional scrutiny regarding mark-to-market discipline in venture funding, particularly when internal revaluations occur absent genuine liquidity milestones.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.